Norman L Lehman

8PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 24, 2023
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo.

Müge Sak, Brian J Williams, Cory T Zumbar

|Jan 05, 2023
Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.

Norman L Lehman

|Apr 20, 2022
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes.

Norman L Lehman, Nathalie Spassky, Müge Sak

|Oct 28, 2021
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms.

Khaled J Alkhateeb, Jason E Crane, Müge Sak

|Apr 24, 2019
Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.

Müge Sak, Cory T Zumbar, Paul D King

|Mar 17, 2019
Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.

Norman L Lehman, Aisulu Usubalieva, Tong Lin

Pageof 2

Frequent Collaborators

2 joint publications

Akshitkumar M Mistry

2 joint publications

Kenneth Aldape

2 joint publications

Eyas M Hattab

2 joint publications

Nathalie Spassky